United Therapeutics | UTHR - Des Atouts





Des Atouts Changement Date
Amarin USD 624.36M 21.4M 2026-06
Ardelyx USD 504.51M 2.9M 2026-03
Baxter International USD 19.79B 55M 2026-06
Bayer EUR 107.29B 659M 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Biogen USD 32.09B 2.6B 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Insmed USD 2.1B 26.7M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 201.06B 167M 2026-06
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Moderna USD 10.96B 527M 2026-06
Omeros USD 200.57M 34.59M 2025-06
Pfizer USD 201.13B 6.49B 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06